Literature DB >> 29397214

Efficacy of Articaine versus Lidocaine in Supplemental Infiltration for Mandibular First versus Second Molars with Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial.

Michael R Shapiro1, Neville J McDonald2, Richard J Gardner3, Mathilde C Peters2, Tatiana M Botero4.   

Abstract

INTRODUCTION: Profound pulpal anesthesia is difficult to achieve in mandibular molars with irreversible pulpitis (IP). However, there are no published randomized controlled clinical trials comparing the success of supplemental buccal infiltration (BI) in mandibular first versus second molars with IP. The purpose of this prospective, randomized, double-blind study was to compare the efficacy of 4% articaine with 2% lidocaine for supplemental BIs in mandibular first versus second molars with IP after a failed inferior alveolar nerve block (IANB). This study's sample was combined with data from a previous trial.
METHODS: One hundred ninety-nine emergency subjects diagnosed with IP of a mandibular molar were selected and received an IANB with 4% articaine. Subjects who failed to achieve profound pulpal anesthesia, determined by a positive response to cold or pain upon access, randomly received 4% articaine or 2% lidocaine as a supplemental BI. Endodontic access was begun 5 minutes after infiltration. Success was defined as less than mild pain during endodontic access and instrumentation on the Heft-Parker visual analog scale.
RESULTS: There was a 25% IANB success rate with 4% articaine. The success rate for articaine supplemental BI in first molars was 61% versus 63% for second molars (P > .05). The success of lidocaine in first molars was 66%, but for second molars it was 32% (P = .004).
CONCLUSIONS: The success rate for IANB with 4% articaine was 25%. Articaine and lidocaine had similar success rates for supplemental infiltration in first molars, whereas articaine was significantly more successful for second molars. However, because BI often did not provide profound pulpal anesthesia, additional techniques including intraosseous anesthesia may still be required.
Copyright © 2018 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Articaine; inferior alveolar nerve block; infiltration; irreversible pulpitis; lidocaine; mandibular molars

Mesh:

Substances:

Year:  2018        PMID: 29397214     DOI: 10.1016/j.joen.2017.10.003

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  8 in total

1.  Anaesthetic Efficacy of 4% Articaine in Comparison with 2% Lidocaine as Intraligamentary Injections after an Ineffective Inferior Alveolar Nerve Block in Mandibular Molars with Irreversible Pulpitis: A Prospective Randomised Triple-Blind Clinical Trial.

Authors:  Nazanin Zargar; Elnaz Shooshtari; Leila Pourmusavi; Alireza Akbarzadeh Baghban; Hengameh Ashraf; Ardavan Parhizkar
Journal:  Pain Res Manag       Date:  2021-05-11       Impact factor: 3.037

2.  The influence of endodontic treatment on blood pressure reduction in patients with vital irreversible pulpitis.

Authors:  Hashim M Hussein; Ahmed S Raafat; Zainab S Amory; Mohammed Jasim Al-Juboori
Journal:  Clin Cosmet Investig Dent       Date:  2019-06-19

3.  Intraosseous anesthesia in symptomatic irreversible pulpitis: Impact of bone thickness on perception and duration of pain.

Authors:  Manfred Nilius; Charlotte Mueller; Minou Helene Nilius; Dominik Haim; Henry Leonhardt; Guenter Lauer
Journal:  J Dent Anesth Pain Med       Date:  2020-12-28

4.  Efficacy of 4% articaine vs 2% lidocaine in mandibular and maxillary block and infiltration anaesthesia in patients with irreversible pulpitis: a systematic review and meta-analysis.

Authors:  Sanjay Miglani; Irfan Ansari; Swadheena Patro; Ankita Mohanty; Shahnaz Mansoori; Bhoomika Ahuja; Mohmed Isaqali Karobari; Krishna Prasad Shetty; Musab Hamed Saeed; Alexander Maniangat Luke; Ajinkya M Pawar
Journal:  PeerJ       Date:  2021-09-24       Impact factor: 2.984

Review 5.  Anesthetic efficacy of supplemental intraligamentary injection in human mandibular teeth with irreversible pulpitis: a systematic review and meta-analysis.

Authors:  Alpa Gupta; Jitesh Wadhwa; Vivek Aggarwal; Namrata Mehta; Dax Abraham; Kritika Aneja; Arundeep Singh
Journal:  J Dent Anesth Pain Med       Date:  2022-01-24

6.  Anesthetic efficacy of supplemental buccal infiltration versus intraligamentary injection in mandibular first and second molars with irreversible pulpitis: a prospective randomized clinical trial.

Authors:  Nazanin Zargar; Shiva Shojaeian; Mohammadreza Vatankhah; Shirin Heidaryan; Hengameh Ashraf; Alireza Akbarzadeh Baghban; Omid Dianat
Journal:  J Dent Anesth Pain Med       Date:  2022-09-27

7.  Comparing Articaine brands: A randomized non-inferiority controlled trial.

Authors:  D Arboleda-Toro; L Toro; Y A Osorio-Osorno; L Castrillon-Pino; N M V Florez-Zapata
Journal:  Heliyon       Date:  2021-06-09

8.  Anesthetic efficacy of articaine/epinephrine plus mannitol in comparison with articaine/epinephrine anesthesia for inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: A randomized controlled clinical trial.

Authors:  Sahar Shakoui; Mostafa Ghodrati; Negin Ghasemi; Tannaz Pourlak; Amir Ardalan Abdollahi
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2019
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.